Global CMO & CDMO Market Research Report 2023

Report ID: 1887826 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CMO & CDMO Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Development
        1.2.3 API production
        1.2.4 Formulation
    1.3 Market by Application
        1.3.1 Global CMO & CDMO Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Pharmaceutical Industry
        1.3.3 Biotechnology
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global CMO & CDMO Market Perspective (2017-2028)
    2.2 CMO & CDMO Growth Trends by Region
        2.2.1 CMO & CDMO Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 CMO & CDMO Historic Market Size by Region (2017-2022)
        2.2.3 CMO & CDMO Forecasted Market Size by Region (2023-2028)
    2.3 CMO & CDMO Market Dynamics
        2.3.1 CMO & CDMO Industry Trends
        2.3.2 CMO & CDMO Market Drivers
        2.3.3 CMO & CDMO Market Challenges
        2.3.4 CMO & CDMO Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top CMO & CDMO Players by Revenue
        3.1.1 Global Top CMO & CDMO Players by Revenue (2017-2022)
        3.1.2 Global CMO & CDMO Revenue Market Share by Players (2017-2022)
    3.2 Global CMO & CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by CMO & CDMO Revenue
    3.4 Global CMO & CDMO Market Concentration Ratio
        3.4.1 Global CMO & CDMO Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CMO & CDMO Revenue in 2021
    3.5 CMO & CDMO Key Players Head office and Area Served
    3.6 Key Players CMO & CDMO Product Solution and Service
    3.7 Date of Enter into CMO & CDMO Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 CMO & CDMO Breakdown Data by Type
    4.1 Global CMO & CDMO Historic Market Size by Type (2017-2022)
    4.2 Global CMO & CDMO Forecasted Market Size by Type (2023-2028)
5 CMO & CDMO Breakdown Data by Application
    5.1 Global CMO & CDMO Historic Market Size by Application (2017-2022)
    5.2 Global CMO & CDMO Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America CMO & CDMO Market Size (2017-2028)
    6.2 North America CMO & CDMO Market Size by Country (2017-2022)
    6.3 North America CMO & CDMO Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe CMO & CDMO Market Size (2017-2028)
    7.2 Europe CMO & CDMO Market Size by Country (2017-2022)
    7.3 Europe CMO & CDMO Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific CMO & CDMO Market Size (2017-2028)
    8.2 Asia-Pacific CMO & CDMO Market Size by Country (2017-2022)
    8.3 Asia-Pacific CMO & CDMO Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America CMO & CDMO Market Size (2017-2028)
    9.2 Latin America CMO & CDMO Market Size by Country (2017-2022)
    9.3 Latin America CMO & CDMO Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa CMO & CDMO Market Size (2017-2028)
    10.2 Middle East & Africa CMO & CDMO Market Size by Country (2017-2022)
    10.3 Middle East & Africa CMO & CDMO Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Recipharm
        11.1.1 Recipharm Company Detail
        11.1.2 Recipharm Business Overview
        11.1.3 Recipharm CMO & CDMO Introduction
        11.1.4 Recipharm Revenue in CMO & CDMO Business (2017-2022)
        11.1.5 Recipharm Recent Development
    11.2 AMRI3
        11.2.1 AMRI3 Company Detail
        11.2.2 AMRI3 Business Overview
        11.2.3 AMRI3 CMO & CDMO Introduction
        11.2.4 AMRI3 Revenue in CMO & CDMO Business (2017-2022)
        11.2.5 AMRI3 Recent Development
    11.3 Patheon
        11.3.1 Patheon Company Detail
        11.3.2 Patheon Business Overview
        11.3.3 Patheon CMO & CDMO Introduction
        11.3.4 Patheon Revenue in CMO & CDMO Business (2017-2022)
        11.3.5 Patheon Recent Development
    11.4 Aenova
        11.4.1 Aenova Company Detail
        11.4.2 Aenova Business Overview
        11.4.3 Aenova CMO & CDMO Introduction
        11.4.4 Aenova Revenue in CMO & CDMO Business (2017-2022)
        11.4.5 Aenova Recent Development
    11.5 Catalent
        11.5.1 Catalent Company Detail
        11.5.2 Catalent Business Overview
        11.5.3 Catalent CMO & CDMO Introduction
        11.5.4 Catalent Revenue in CMO & CDMO Business (2017-2022)
        11.5.5 Catalent Recent Development
    11.6 Amatsigroup
        11.6.1 Amatsigroup Company Detail
        11.6.2 Amatsigroup Business Overview
        11.6.3 Amatsigroup CMO & CDMO Introduction
        11.6.4 Amatsigroup Revenue in CMO & CDMO Business (2017-2022)
        11.6.5 Amatsigroup Recent Development
    11.7 WuXi PharmaTech
        11.7.1 WuXi PharmaTech Company Detail
        11.7.2 WuXi PharmaTech Business Overview
        11.7.3 WuXi PharmaTech CMO & CDMO Introduction
        11.7.4 WuXi PharmaTech Revenue in CMO & CDMO Business (2017-2022)
        11.7.5 WuXi PharmaTech Recent Development
    11.8 Strides Shasun
        11.8.1 Strides Shasun Company Detail
        11.8.2 Strides Shasun Business Overview
        11.8.3 Strides Shasun CMO & CDMO Introduction
        11.8.4 Strides Shasun Revenue in CMO & CDMO Business (2017-2022)
        11.8.5 Strides Shasun Recent Development
    11.9 Piramal
        11.9.1 Piramal Company Detail
        11.9.2 Piramal Business Overview
        11.9.3 Piramal CMO & CDMO Introduction
        11.9.4 Piramal Revenue in CMO & CDMO Business (2017-2022)
        11.9.5 Piramal Recent Development
    11.10 Siegfried
        11.10.1 Siegfried Company Detail
        11.10.2 Siegfried Business Overview
        11.10.3 Siegfried CMO & CDMO Introduction
        11.10.4 Siegfried Revenue in CMO & CDMO Business (2017-2022)
        11.10.5 Siegfried Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global CMO & CDMO Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Development
    Table 3. Key Players of API production
    Table 4. Key Players of Formulation
    Table 5. Global CMO & CDMO Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global CMO & CDMO Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global CMO & CDMO Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global CMO & CDMO Market Share by Region (2017-2022)
    Table 9. Global CMO & CDMO Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global CMO & CDMO Market Share by Region (2023-2028)
    Table 11. CMO & CDMO Market Trends
    Table 12. CMO & CDMO Market Drivers
    Table 13. CMO & CDMO Market Challenges
    Table 14. CMO & CDMO Market Restraints
    Table 15. Global CMO & CDMO Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global CMO & CDMO Market Share by Players (2017-2022)
    Table 17. Global Top CMO & CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO & CDMO as of 2021)
    Table 18. Ranking of Global Top CMO & CDMO Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by CMO & CDMO Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players CMO & CDMO Product Solution and Service
    Table 22. Date of Enter into CMO & CDMO Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global CMO & CDMO Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global CMO & CDMO Revenue Market Share by Type (2017-2022)
    Table 26. Global CMO & CDMO Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global CMO & CDMO Revenue Market Share by Type (2023-2028)
    Table 28. Global CMO & CDMO Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global CMO & CDMO Revenue Market Share by Application (2017-2022)
    Table 30. Global CMO & CDMO Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global CMO & CDMO Revenue Market Share by Application (2023-2028)
    Table 32. North America CMO & CDMO Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America CMO & CDMO Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe CMO & CDMO Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe CMO & CDMO Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific CMO & CDMO Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific CMO & CDMO Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America CMO & CDMO Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America CMO & CDMO Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa CMO & CDMO Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa CMO & CDMO Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Recipharm Company Detail
    Table 43. Recipharm Business Overview
    Table 44. Recipharm CMO & CDMO Product
    Table 45. Recipharm Revenue in CMO & CDMO Business (2017-2022) & (US$ Million)
    Table 46. Recipharm Recent Development
    Table 47. AMRI3 Company Detail
    Table 48. AMRI3 Business Overview
    Table 49. AMRI3 CMO & CDMO Product
    Table 50. AMRI3 Revenue in CMO & CDMO Business (2017-2022) & (US$ Million)
    Table 51. AMRI3 Recent Development
    Table 52. Patheon Company Detail
    Table 53. Patheon Business Overview
    Table 54. Patheon CMO & CDMO Product
    Table 55. Patheon Revenue in CMO & CDMO Business (2017-2022) & (US$ Million)
    Table 56. Patheon Recent Development
    Table 57. Aenova Company Detail
    Table 58. Aenova Business Overview
    Table 59. Aenova CMO & CDMO Product
    Table 60. Aenova Revenue in CMO & CDMO Business (2017-2022) & (US$ Million)
    Table 61. Aenova Recent Development
    Table 62. Catalent Company Detail
    Table 63. Catalent Business Overview
    Table 64. Catalent CMO & CDMO Product
    Table 65. Catalent Revenue in CMO & CDMO Business (2017-2022) & (US$ Million)
    Table 66. Catalent Recent Development
    Table 67. Amatsigroup Company Detail
    Table 68. Amatsigroup Business Overview
    Table 69. Amatsigroup CMO & CDMO Product
    Table 70. Amatsigroup Revenue in CMO & CDMO Business (2017-2022) & (US$ Million)
    Table 71. Amatsigroup Recent Development
    Table 72. WuXi PharmaTech Company Detail
    Table 73. WuXi PharmaTech Business Overview
    Table 74. WuXi PharmaTech CMO & CDMO Product
    Table 75. WuXi PharmaTech Revenue in CMO & CDMO Business (2017-2022) & (US$ Million)
    Table 76. WuXi PharmaTech Recent Development
    Table 77. Strides Shasun Company Detail
    Table 78. Strides Shasun Business Overview
    Table 79. Strides Shasun CMO & CDMO Product
    Table 80. Strides Shasun Revenue in CMO & CDMO Business (2017-2022) & (US$ Million)
    Table 81. Strides Shasun Recent Development
    Table 82. Piramal Company Detail
    Table 83. Piramal Business Overview
    Table 84. Piramal CMO & CDMO Product
    Table 85. Piramal Revenue in CMO & CDMO Business (2017-2022) & (US$ Million)
    Table 86. Piramal Recent Development
    Table 87. Siegfried Company Detail
    Table 88. Siegfried Business Overview
    Table 89. Siegfried CMO & CDMO Product
    Table 90. Siegfried Revenue in CMO & CDMO Business (2017-2022) & (US$ Million)
    Table 91. Siegfried Recent Development
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CMO & CDMO Market Share by Type: 2021 VS 2028
    Figure 2. Development Features
    Figure 3. API production Features
    Figure 4. Formulation Features
    Figure 5. Global CMO & CDMO Market Share by Application in 2021 & 2028
    Figure 6. Pharmaceutical Industry Case Studies
    Figure 7. Biotechnology Case Studies
    Figure 8. Other Case Studies
    Figure 9. CMO & CDMO Report Years Considered
    Figure 10. Global CMO & CDMO Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global CMO & CDMO Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global CMO & CDMO Market Share by Region: 2021 VS 2028
    Figure 13. Global CMO & CDMO Market Share by Players in 2021
    Figure 14. Global Top CMO & CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO & CDMO as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by CMO & CDMO Revenue in 2021
    Figure 16. North America CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America CMO & CDMO Market Share by Country (2017-2028)
    Figure 18. United States CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe CMO & CDMO Market Share by Country (2017-2028)
    Figure 22. Germany CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific CMO & CDMO Market Share by Region (2017-2028)
    Figure 30. China CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America CMO & CDMO Market Share by Country (2017-2028)
    Figure 38. Mexico CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa CMO & CDMO Market Share by Country (2017-2028)
    Figure 42. Turkey CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia CMO & CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Recipharm Revenue Growth Rate in CMO & CDMO Business (2017-2022)
    Figure 45. AMRI3 Revenue Growth Rate in CMO & CDMO Business (2017-2022)
    Figure 46. Patheon Revenue Growth Rate in CMO & CDMO Business (2017-2022)
    Figure 47. Aenova Revenue Growth Rate in CMO & CDMO Business (2017-2022)
    Figure 48. Catalent Revenue Growth Rate in CMO & CDMO Business (2017-2022)
    Figure 49. Amatsigroup Revenue Growth Rate in CMO & CDMO Business (2017-2022)
    Figure 50. WuXi PharmaTech Revenue Growth Rate in CMO & CDMO Business (2017-2022)
    Figure 51. Strides Shasun Revenue Growth Rate in CMO & CDMO Business (2017-2022)
    Figure 52. Piramal Revenue Growth Rate in CMO & CDMO Business (2017-2022)
    Figure 53. Siegfried Revenue Growth Rate in CMO & CDMO Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Recipharm
AMRI3
Patheon
Aenova
Catalent
Amatsigroup
WuXi PharmaTech
Strides Shasun
Piramal
Siegfried
Frequently Asked Questions
CMO & CDMO report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CMO & CDMO report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CMO & CDMO report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Chlortetracycline

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More